Amanote Research
Register
Sign In
Cost-Effectiveness of Saxagliptin and Linagliptin in Combination With Metformin for Type II Diabetes: A Decision-Tree Analysis Model
Value in Health
- United Kingdom
doi 10.1016/j.jval.2014.03.1461
Full Text
Open PDF
Abstract
Available in
full text
Categories
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Date
May 1, 2014
Authors
R.V. Sawant
S.S. Sansgiry
Publisher
Elsevier BV
Related search
Cost-Effectiveness Analysis of Linagliptin Versus Sulfonylurea as Add-On Treatment to Metformin for the Treatment of Diabetes Mellitus Type 2 Patients in Indonesia
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Cost-Effectiveness of First-Line Versus Delayed Use of Combination Dapagliflozin and Metformin in Patients With Type 2 Diabetes
Scientific Reports
Multidisciplinary
Combination of Empagliflozin and Linagliptin as Second-Line Therapy in Subjects With Type 2 Diabetes Inadequately Controlled on Metformin
Diabetes Care
Internal Medicine
Endocrinology
Advanced
Metabolism
Specialized Nursing
Diabetes
Cost Effectiveness Evaluation of Canagliflozin in Combination With Metformin in the Treatment of Type 2 Diabetes Mellitus in Poland
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Saxagliptin/Metformin Extended-Release (XR) for the Type 2 Diabetes (T2DM) Treatment in Venezuela: A Budget Impact Analysis
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Identification of Potential Type II Diabetes in a Chinese Population With a Sensitive Decision Tree Approach
Journal of Diabetes Research
Endocrinology
Metabolism
Diabetes
Analysis of Decision Tree for Diabetes Prediction
International Journal of Engineering and Technical Research (IJETR)
Empagliflozin and Metformin Combination Therapy in Type 2 Diabetes Mellitus
International Journal of Basic and Clinical Pharmacology
Budget Impact Analysis of the Introduction of Saxagliptin/Metformin Extended-Release (Xr) in the Treatment of Type-2 Diabetes in Chile
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
